November 04, 2025 17:21 ET | Source: Urgent.ly Inc. ASHBURN, Va., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Urgent.ly Inc. (Nasdaq:…
November 04, 2025 17:06 ET | Source: Topicus.com Inc. TORONTO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) in…
CHICAGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Misophonia Research Fund (MRF), an initiative of the REAM Foundation, announces a…
New preclinical results demonstrate the potential of ARD-201 in enhanced glucose control, along with preservation of lean mass, underscoring its…
CHARLOTTESVILLE, Va. and SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company…
New York City, NY, Nov. 03, 2025 (GLOBE NEWSWIRE) -- When markets are filled with uncertainty, the only way to…
PHILADELPHIA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- via IBN – Datavault AI Inc. (Nasdaq: DVLT), a leader in AI-driven data…
Lagos, Algarve, Portugal, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Algarve will once again take centre stage in Europe’s innovation…
November 03, 2025 16:45 ET | Source: Fulcrum Therapeutics, Inc. ― Pociredir Phase 1b PIONEER Trial Data in Sickle Cell…
EDEN PRAIRIE, Minn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading…